Media coverage
3
Media coverage
Title U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis Media name/outlet BioSpace Country/Territory United States Date 27/09/23 URL ct.moreover.com/?a=51920209043&p=1gw&v=1&x=HWQEyw2zc67lgGNx0xXeCg Persons Bruce E. Sands Title U.S. FDA Approves Subcutaneous Administration of Media name/outlet Sogotrade - Barchart.com Country/Territory United States Date 27/09/23 URL ct.moreover.com/?a=51916674827&p=1gw&v=1&x=5h-inyPWMElP-wuI47f4rQ Persons Bruce E. Sands Title U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis Media name/outlet Jotup Country/Territory United States Date 27/09/23 URL ct.moreover.com/?a=51917987435&p=1gw&v=1&x=O7GyuQbC564hV5KPtQ8l5A Persons Bruce E. Sands